Original Article
Modern Pathology (2008) 21, 1517–1526; doi:10.1038/modpathol.2008.159; published online 26 September 2008
Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States
Hisashi Takino1, Chunmei Li1, Sindy Hu2, Tseng-Tong Kuo3, Eva Geissinger4, Hans Konrad Muller-Hermelink4, Bong Kim5, Steven H Swerdlow5 and Hiroshi Inagaki1
- 1Department of Pathology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
- 2Department of Dermatology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
- 3Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
- 4Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany
- 5Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA
Correspondence: Dr H Inagaki, MD, Department of Pathology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan. E-mail: hinagaki@med.nagoya-cu.ac.jp
Received 16 May 2008; Revised 18 August 2008; Accepted 19 August 2008; Published online 26 September 2008.
Abstract
Primary cutaneous marginal zone B-cell lymphoma is considered the cutaneous counterpart of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Although its molecular pathogenesis is currently unknown, an etiological link with Borrelia burgdorferi infection has been identified in European, but not in American or Asian cases. To better understand the pathogenesis and the geographical differences of cutaneous marginal zone B-cell lymphoma, 60 cases from the East Asia, Germany, and the United States at their initial presentation were subjected to the following analyses; (1) clinicopathological comparison between the geographical regions, (2) detection of B. burgdorferi DNA, (3) detection of the API2–MALT1 fusion transcript, a gene alteration specific to mucosa-associated lymphoid tissue lymphoma, and (4) inactivation of tumor suppressor genes (death-associated protein kinase (DAPK), p16INK4a, p14ARF, MGMT, TIMP3, CDH1, and RARB) by hypermethylation of the CpG islands. Cases from the three geographical regions showed similar clinicopathological features. However, moderate/marked tissue eosinophilia was found in 9/25 Asian cases, but only 1/23 German cases (P=0.011) and 0/12 American cases (P=0.015). All 60 cases were negative for either Borrelia DNA or API2–MALT1 fusion. Tumors from the three regions were highly methylated for DAPK (38–50% of the cases, mean 43%) and p16INK4a (42–70%, mean 49%), and the positivities were significantly higher than those of nonneoplastic skin (8%, P=0.0010 and 14%, P=0.0032, respectively). Methylation of these genes had no significant association with progressive features of the tumor. Primary cutaneous marginal zone B-cell lymphomas from the three geographical regions have common clinicopathological features, however, moderate/marked tissue eosinophilia is a feature found almost exclusively in Asian cases. Borrelia infection and API2–MALT1 fusion are not significant in this tumor. Methylation of DAPK and p16INK4a genes is a frequent event in this lymphoma at its initial presentation, but may not be associated with tumor progression.
Keywords:
primary cutaneous marginal zone B-cell lymphoma, molecular and clinicopathological study, international study
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Chlamydial infection: the link with ocular adnexal lymphomas
Nature Reviews Clinical Oncology Review (01 Nov 2009)
RESEARCH
Modern Pathology Original Article
Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma
Modern Pathology Original Article
Cutaneous Presentation of Follicular Lymphomas
Modern Pathology Correspondence
Primary Cutaneous Marginal Zone B-Cell Lymphomas Are Targeted by Aberrant Somatic Hypermutation
Journal of Investigative Dermatology Original Article

